Insider Trading: Actavis PLC (ACT)

ACT on New York Consolidated

197.39USD
17 Apr 2014
Price Change (% chg)

$-1.99 (-1.00%)
Prev Close
$199.38
Open
$198.49
Day's High
$200.88
Day's Low
$195.37
Volume
1,522,676
Avg. Vol
2,890,740
52-wk High
$230.77
52-wk Low
$96.52

Search Stocks
JOYCE ROBERT TODD Options Exercised: 0
Trade Date: Tuesday, 5 Mar 2013 Price: 0.00
Title: Officer Shares Held: 99,684
Type Traded: Direct Net Change in Shares This Filing: 14,676

Institutional Holders

% Shares Owned: 86.80%
# of Holders: 747
Total Shares Held: 151,455,824
3 Mo. Net Change: 967,301
# New Positions: 17
# Closed Positions: 6
# Increased Positions: 48
# Reduced Positions: 49
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

Paul Bisaro

52 2013 Chairman of the Board, President, Chief Executive Officer

Sigurdur Olafsson

45 2013 President - Actavis Pharma, Director

Robert Stewart

45 2014 President - Global Manufacturing and Distribution

George Wilkinson

57 2014 President - Actavis Global Research and Development

James D'Arecca

42 2013 Chief Accounting Officer

David Buchen

48 2012 Chief Legal Officer, Global

Patrick Eagan

55 2012 Chief Human Resource Officer, Global

R. Todd Joyce

55 2012 Chief Financial Officer, Global

Charles Mayr

56 2012 Chief Communication Officer, Global

Andrew Turner

66 2013 Lead Independent Director

James Bloem

62 2013 Director

Tamar Howson

65 2013 Director

John King

59 2013 Director

Jiri Michal

62 2013 Director

Patrick O'Sullivan

71 2013 Director

Christopher Bodine

57 2009 Independent Director

Catherine Klema

54 2004 Independent Director

Jack Michelson

78 2002 Independent Director

Ronald Taylor

65 1994 Independent Director

Fred Weiss

71 2000 Independent Director

Lisa DeFrancesco

Vice President, Global Investor Relations
Search Stocks